DIFFERENT AWARENESS OF HYPOGLYCEMIA INDUCED BY HUMAN OR PURIFIED PORK INSULIN IN TYPE-I DIABETIC-PATIENTS

被引:6
|
作者
LINGENFELSER, T [1 ]
OVERKAMP, D [1 ]
RENN, W [1 ]
GLUCK, H [1 ]
MAASSEN, M [1 ]
EGGSTEIN, M [1 ]
JAKOBER, B [1 ]
机构
[1] UNIV TUBINGEN,DEPT ENDOCRINOL,W-7400 TUBINGEN 1,GERMANY
关键词
DIABETES-MELLITUS; IDDM; HYPOGLYCEMIA; UNAWARENESS; AUTONOMIC AND NEUROGLYCOPENIC SYMPTOMS; HORMONAL COUNTERREGULATION;
D O I
10.1016/0168-8227(91)90030-H
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recently, there have been reports on a diminished awareness of hypoglycaemia after a switch from purified pork insulin (PPI) to human insulin (HI) in insulin-dependent diabetes mellitus (IDDM). To clarify this phenomenon we investigated nine IDDM patients without signs of autonomic neuropathy. After an overnight euglycaemic clamp, blood glucose was lowered to hypoglycaemic levels by means of an artificial pancreas (Biostator) on 2 days. Insulin was used in a double-blind, randomized, cross-over fashion, either PPI or HI. The symptomatology and the hormonal counterregulation of developing hypoglycaemia was recorded. Venous concentrations of free insulin, cortisol, glucagon, growth hormone and the prevailing blood glucose were similar under both insulins. Eight out of nine IDDM patients felt more symptoms and at a higher blood glucose concentration under PPI than under HI. The first symptom of developing hypoglycaemia appeared at a mean blood glucose concentration of 61.1 +/- 5.4 mg.dl-1 under PPI and 44.4 +/- 5.3 mg.dl-1 under HI respectively (P < 0.05). We conclude that HI may cause symptoms of hypoglycaemia to appear later and with a lesser number in comparison to PPI.
引用
收藏
页码:29 / 36
页数:8
相关论文
共 50 条
  • [31] ABNORMAL ACTION OF CATECHOLAMINES ON LIPOLYSIS IN ADIPOCYTES OF TYPE-I DIABETIC-PATIENTS TREATED WITH INSULIN
    WAHRENBERG, H
    LONNQVIST, F
    ENGFELDT, P
    ARNER, P
    DIABETES, 1989, 38 (04) : 524 - 533
  • [32] PRODUCTS OF THERAPEUTIC INSULINS IN THE BLOOD OF INSULIN-DEPENDENT (TYPE-I) DIABETIC-PATIENTS
    ROBBINS, DC
    SHOELSON, SE
    TAGER, HS
    MEAD, PM
    GAYNOR, DH
    DIABETES, 1985, 34 (05) : 510 - 519
  • [33] SUBCUTANEOUS PERITONEAL ACCESS DEVICE FOR TYPE-I DIABETIC-PATIENTS NONRESPONSIVE TO SUBCUTANEOUS INSULIN
    SCHADE, DS
    EATON, RP
    WARHOL, RM
    GREGORY, JA
    DOBERNECK, RC
    DIABETES, 1982, 31 (05) : 470 - 473
  • [34] POSTPRANDIAL EXERCISE IN TYPE-I DIABETIC-PATIENTS ON MULTIPLE DAILY INSULIN INJECTION REGIMEN
    TROVATI, M
    ANFOSSI, G
    VITALI, S
    MULARONI, E
    MASSUCCO, P
    DEFACIS, R
    CARTA, Q
    LUCCHINA, PG
    EMANUELLI, G
    DIABETES CARE, 1988, 11 (02) : 107 - 110
  • [35] INSULIN AUTOANTIBODIES IN 1ST DEGREE RELATIVES OF TYPE-I DIABETIC-PATIENTS
    PINHEIRO, MFMC
    DIB, SA
    CASTRO, AMS
    VIEIRA, JGH
    RUSSO, EMK
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1992, 25 (03) : 231 - 238
  • [36] INSULIN-ANTIBODIES AND PEPTIDE-C SECRETION IN TYPE-I DIABETIC-PATIENTS
    VELASCO, N
    DEVALDES, MD
    ARTEAGA, A
    ACOSTA, AM
    PELLEGRINI, MR
    FORADORI, A
    REVISTA MEDICA DE CHILE, 1990, 118 (01) : 3 - 9
  • [37] AMINO-ACIDS (AA) ENHANCE GLUCOSE (G) RECOVERY AND GLUCAGON (GLN) SECRETION DURING INSULIN-INDUCED HYPOGLYCEMIA IN TYPE-I DIABETIC-PATIENTS
    NADEAU, DA
    NAIR, KS
    CLINICAL RESEARCH, 1991, 39 (02): : A385 - A385
  • [38] HYPOGLYCEMIA AND SITE OF INSULIN INJECTION IN DIABETIC-PATIENTS
    CANIVET, B
    PEHUET, M
    NOUVELLE PRESSE MEDICALE, 1982, 11 (38): : 2851 - 2851
  • [39] ABNORMALITIES IN LIPOPROTEINS AND FIBRINOGEN IN TYPE-I (INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH DIFFERENT LEVELS OF URINARY ALBUMIN EXCRETION
    JENSEN, T
    STENDER, S
    DECKERT, T
    ACTA ENDOCRINOLOGICA, 1987, 115 : 24 - 24
  • [40] INCREASED FIBRINOLYTIC POTENTIAL INDUCED BY GLICLAZIDE IN TYPE-I AND TYPE-II DIABETIC-PATIENTS
    GRAM, J
    JESPERSEN, J
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (05): : 25 - 29